Avanos Medical, Inc.AVNSNYSE
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank31
3Y CAGR-78.0%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-78.0%/yr
Quarterly compound
Percentile
P31
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 0.03% |
| Q3 2025 | -0.43% |
| Q2 2025 | -7.52% |
| Q1 2025 | 1.10% |
| Q4 2024 | -32.63% |
| Q3 2024 | 0.41% |
| Q2 2024 | 0.17% |
| Q1 2024 | -0.68% |
| Q4 2023 | 2.48% |
| Q3 2023 | -1.03% |
| Q2 2023 | -5.33% |
| Q1 2023 | 0.37% |
| Q4 2022 | 2.41% |
| Q3 2022 | 2.25% |
| Q2 2022 | 0.03% |
| Q1 2022 | 0.56% |
| Q4 2021 | 0.48% |
| Q3 2021 | -2.65% |
| Q2 2021 | 2.20% |
| Q1 2021 | 0.32% |
| Q4 2020 | -2.59% |
| Q3 2020 | 2.24% |
| Q2 2020 | 0.41% |
| Q1 2020 | -1.10% |
| Q4 2019 | 0.08% |
| Q3 2019 | -2.12% |
| Q2 2019 | 0.07% |
| Q1 2019 | -0.92% |
| Q4 2018 | -0.44% |
| Q3 2018 | 0.63% |
| Q2 2018 | 2.34% |
| Q1 2018 | 2.99% |
| Q4 2017 | 1.76% |
| Q3 2017 | 2.81% |
| Q2 2017 | 2.29% |
| Q1 2017 | 2.58% |
| Q4 2016 | 0.09% |
| Q3 2016 | 1.10% |
| Q2 2016 | 0.71% |
| Q1 2016 | 2.32% |